Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries
PURPOSEThis study aimed to identify, evaluate, and rank suitable safety innovations developed during the COVID-19 pandemic in Latin American and Caribbean (LAC) radiation oncology centers.METHODSWe conducted a multimodal participatory engagement collaboration with the Latin-American and Caribbean So...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
American Society of Clinical Oncology
2024-08-01
|
| סדרה: | JCO Global Oncology |
| גישה מקוונת: | https://ascopubs.org/doi/10.1200/GO.24.00051 |
| _version_ | 1827144792829591552 |
|---|---|
| author | Ivy Riano César Alas-Pineda Sarahi Reyes Garcia Raúl Murillo Francisco Gutiérrez-Delgado Eduardo Cazap Celia Maria Pais Viegas Marcela de la Torre Kaory C. Barahona Gustavo J. Sarria Ramón del Castillo Bahi Álvaro Luongo-Céspedes Beatriz Ovalles Flory Vanessa Umaña Herrera Ricardo Sánchez Shauna McVorran Benjamin Williams Joseph Kascmar Linda S. Kennedy Kathleen D. Lyons Suyapa Bejarano Sandra L. Wong |
| author_facet | Ivy Riano César Alas-Pineda Sarahi Reyes Garcia Raúl Murillo Francisco Gutiérrez-Delgado Eduardo Cazap Celia Maria Pais Viegas Marcela de la Torre Kaory C. Barahona Gustavo J. Sarria Ramón del Castillo Bahi Álvaro Luongo-Céspedes Beatriz Ovalles Flory Vanessa Umaña Herrera Ricardo Sánchez Shauna McVorran Benjamin Williams Joseph Kascmar Linda S. Kennedy Kathleen D. Lyons Suyapa Bejarano Sandra L. Wong |
| author_sort | Ivy Riano |
| collection | DOAJ |
| description | PURPOSEThis study aimed to identify, evaluate, and rank suitable safety innovations developed during the COVID-19 pandemic in Latin American and Caribbean (LAC) radiation oncology centers.METHODSWe conducted a multimodal participatory engagement collaboration with the Latin-American and Caribbean Society of Medical Oncology. The study consisted of four phases. Innovations were collected from a panel of radiotherapy experts representing a diverse group of 11 countries from LAC (Phase I). Next, a medical scientific team compared the innovations against international standards regarding their potential impact on risk of infection, clinical operation, and continuity of quality cancer care (Phase II). Their findings were supplied to the country representatives who rated the innovations for acceptability in their cancer centers (Phase III), resulting in a final report of the panel's recommendations (Phase IV).RESULTSA total of 81 innovations were reported by the country representatives and merged by the medical scientific team into 24 innovations that combined similar innovations. The 24 innovations were grouped into six categories including practices aimed at (1) reducing clinic crowding (n = 3), (2) increasing screening and vaccinations for COVID-19 disease (n = 5), (3) implementing social distancing (n = 6), (4) strengthening personal infection equipment and disinfection (n = 6), (5) avoiding delaying or shortening treatment protocols (n = 2), and (6) mixed procedures (n = 2). The medical scientific team found nearly all innovations were supported by international recommendations and rated as safe, efficient, and acceptable.CONCLUSIONBy using the lessons learned from the Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated study, a manual of scalable practices in radiation oncology clinics may be developed to guide actions during future large-scale public health crises in low- and middle-income countries of LAC. |
| first_indexed | 2025-03-20T20:04:21Z |
| format | Article |
| id | doaj.art-d002434b01c64e11b51c4e73d520b79a |
| institution | Directory Open Access Journal |
| issn | 2687-8941 |
| language | English |
| last_indexed | 2025-03-20T20:04:21Z |
| publishDate | 2024-08-01 |
| publisher | American Society of Clinical Oncology |
| record_format | Article |
| series | JCO Global Oncology |
| spelling | doaj.art-d002434b01c64e11b51c4e73d520b79a2024-08-19T19:59:26ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412024-08-011010.1200/GO.24.00051Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean CountriesIvy Riano0César Alas-Pineda1Sarahi Reyes Garcia2Raúl Murillo3Francisco Gutiérrez-Delgado4Eduardo Cazap5Celia Maria Pais Viegas6Marcela de la Torre7Kaory C. Barahona8Gustavo J. Sarria9Ramón del Castillo Bahi10Álvaro Luongo-Céspedes11Beatriz Ovalles12Flory Vanessa Umaña Herrera13Ricardo Sánchez14Shauna McVorran15Benjamin Williams16Joseph Kascmar17Linda S. Kennedy18Kathleen D. Lyons19Suyapa Bejarano20Sandra L. Wong21Division of Hematology and Oncology, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NHDivision of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, HondurasDivision of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, HondurasCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, ColombiaCentro de Estudios y Prevención del Cáncer, Latin American School of Oncology, Tuxtla Gutiérrez, MéxicoLatin-American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, ArgentinaDepartment of Radiation Oncology, Instituto Nacional de Cáncer, Brazil National Cancer Institute, Rio de Janeiro, BrazilDivision of Oncology, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, ArgentinaDivision of Radiation Oncology, International Cancer Center, Diagnostic Hospital, San Salvador, El SalvadorDirección General de Control de Cancer, Instituto Nacional de Enfermedades Neoplásicas, Lima, PeruDepartment of Radiation Oncology, Instituto Nacional de Oncología y Radiobiología, La Habana, CubaInstituto Nacional de Cáncer, Montevideo, UruguayDepartment of Radiation Oncology, Centro de Cancer Homs, Santiago de los Caballeros, Dominican RepublicDepartment of Radiation Oncology, Caja Costarricense de Seguro Social (CCSS), San José, Costa RicaCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, ColombiaDepartment of Radiation Oncology and Applied Science, Dartmouth Cancer Center, Lebanon, NHDepartment of Radiation Oncology and Applied Science, Dartmouth Cancer Center, Lebanon, NHDepartment of Surgery, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NHStrategic Initiatives & Global Oncology at the Dartmouth Cancer Center, Dartmouth Health, Lebanon, NHDepartment of Occupational Therapy, Massachusetts General Hospital (MGH) Institute of Health Professions, Boston, MADivision of Radiation Oncology, Liga Contra El Cáncer, San Pedro Sula, HondurasDepartment of Surgery, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NHPURPOSEThis study aimed to identify, evaluate, and rank suitable safety innovations developed during the COVID-19 pandemic in Latin American and Caribbean (LAC) radiation oncology centers.METHODSWe conducted a multimodal participatory engagement collaboration with the Latin-American and Caribbean Society of Medical Oncology. The study consisted of four phases. Innovations were collected from a panel of radiotherapy experts representing a diverse group of 11 countries from LAC (Phase I). Next, a medical scientific team compared the innovations against international standards regarding their potential impact on risk of infection, clinical operation, and continuity of quality cancer care (Phase II). Their findings were supplied to the country representatives who rated the innovations for acceptability in their cancer centers (Phase III), resulting in a final report of the panel's recommendations (Phase IV).RESULTSA total of 81 innovations were reported by the country representatives and merged by the medical scientific team into 24 innovations that combined similar innovations. The 24 innovations were grouped into six categories including practices aimed at (1) reducing clinic crowding (n = 3), (2) increasing screening and vaccinations for COVID-19 disease (n = 5), (3) implementing social distancing (n = 6), (4) strengthening personal infection equipment and disinfection (n = 6), (5) avoiding delaying or shortening treatment protocols (n = 2), and (6) mixed procedures (n = 2). The medical scientific team found nearly all innovations were supported by international recommendations and rated as safe, efficient, and acceptable.CONCLUSIONBy using the lessons learned from the Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated study, a manual of scalable practices in radiation oncology clinics may be developed to guide actions during future large-scale public health crises in low- and middle-income countries of LAC.https://ascopubs.org/doi/10.1200/GO.24.00051 |
| spellingShingle | Ivy Riano César Alas-Pineda Sarahi Reyes Garcia Raúl Murillo Francisco Gutiérrez-Delgado Eduardo Cazap Celia Maria Pais Viegas Marcela de la Torre Kaory C. Barahona Gustavo J. Sarria Ramón del Castillo Bahi Álvaro Luongo-Céspedes Beatriz Ovalles Flory Vanessa Umaña Herrera Ricardo Sánchez Shauna McVorran Benjamin Williams Joseph Kascmar Linda S. Kennedy Kathleen D. Lyons Suyapa Bejarano Sandra L. Wong Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries JCO Global Oncology |
| title | Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries |
| title_full | Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries |
| title_fullStr | Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries |
| title_full_unstemmed | Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries |
| title_short | Community-Led Action Research in Oncology: Pandemic-Appropriate Radiotherapy Innovations Evaluated (CLARO PARTE) for Latin America and the Caribbean Countries |
| title_sort | community led action research in oncology pandemic appropriate radiotherapy innovations evaluated claro parte for latin america and the caribbean countries |
| url | https://ascopubs.org/doi/10.1200/GO.24.00051 |
| work_keys_str_mv | AT ivyriano communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT cesaralaspineda communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT sarahireyesgarcia communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT raulmurillo communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT franciscogutierrezdelgado communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT eduardocazap communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT celiamariapaisviegas communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT marceladelatorre communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT kaorycbarahona communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT gustavojsarria communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT ramondelcastillobahi communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT alvaroluongocespedes communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT beatrizovalles communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT floryvanessaumanaherrera communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT ricardosanchez communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT shaunamcvorran communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT benjaminwilliams communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT josephkascmar communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT lindaskennedy communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT kathleendlyons communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT suyapabejarano communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries AT sandralwong communityledactionresearchinoncologypandemicappropriateradiotherapyinnovationsevaluatedclaroparteforlatinamericaandthecaribbeancountries |